"In The Spotlight" Archive
Three teams headed by researchers at the Stanford University School of Medicine recently received $51.7 million from the California Institute for Regenerative Medicine to develop The team headed by Alfred Lane, MD, professor of dermatology will receive $11.7 million to use stem cell therapy to treat epidermolysis bullosa or EB, a devastating genetic skin condition. The international group also includes Stanford stem cell expert Marius Wernig, MD, as well as Stanford researchers Paul Khavari, MD, PhD, Peter Marinkovich, MD, Howard Chang, MD, PhD, Anthony Oro, MD, PhD, and |
||||
 |
||||
Howard Chang, MD, PhD. associate professor of dermatology and a member of Stanford's Cancer Center on his latest research... More » |
||||
 |
||||
Youn Kim, MD, (second from left, front row) |
||||
Stanford research discovers that specialized skin cells use a mapping system to identify where they belong in the body. John Rinn, PhD, a postdoctoral scholar in the laboratory of Howard Chang, MD, PhD, assistant professor of dermatology, speaks on their research... More » |
||||
|
||||
Derm Intranet